Liuzhe Zhang, David Clever, Aaron M Gazendam, Anthony M Griffin, Kim Tsoi, Peter C Ferguson, Jay S Wunder
{"title":"Extended Curettage for Local Control of Chondromyxoid Fibroma: A 33-Year Experience at a Single Tertiary Center.","authors":"Liuzhe Zhang, David Clever, Aaron M Gazendam, Anthony M Griffin, Kim Tsoi, Peter C Ferguson, Jay S Wunder","doi":"10.1002/jso.70385","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The management of chondromyxoid fibroma (CMF) primarily relies on surgical resection, but simple curettage is reportedly associated with a high local recurrence rate. While extended curettage with high-speed burring effectively manages other locally aggressive bone tumors, its effectiveness for CMF remains unclear. We aimed to evaluate the outcome of this technique for CMF.</p><p><strong>Methods: </strong>We retrospectively reviewed 31 CMF patients treated at a single tertiary academic hospital between 1990 and 2023. Demographics and treatment details were collected. The primary outcome was local recurrence-free survival for the patients who underwent extended curettage and had follow-up for more than 6 months. The secondary outcome was complications.</p><p><strong>Results: </strong>The median age was 41 (IQR, 18-47), and 61% were male. Of the total 31 patients, 26 underwent extended curettage with high-speed burring, while five underwent en bloc resection. No local recurrence occurred in either group. Among the extended curettage group, 21 had a follow-up of more than 6 months (median follow-up: 37 months [IQR, 18-58 months]), only one complication (symptomatic hardware removal) was recorded.</p><p><strong>Conclusions: </strong>Extended curettage with high-speed burring was associated with excellent local control and few complications, making it a desirable surgical option for CMF.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.70385","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: The management of chondromyxoid fibroma (CMF) primarily relies on surgical resection, but simple curettage is reportedly associated with a high local recurrence rate. While extended curettage with high-speed burring effectively manages other locally aggressive bone tumors, its effectiveness for CMF remains unclear. We aimed to evaluate the outcome of this technique for CMF.
Methods: We retrospectively reviewed 31 CMF patients treated at a single tertiary academic hospital between 1990 and 2023. Demographics and treatment details were collected. The primary outcome was local recurrence-free survival for the patients who underwent extended curettage and had follow-up for more than 6 months. The secondary outcome was complications.
Results: The median age was 41 (IQR, 18-47), and 61% were male. Of the total 31 patients, 26 underwent extended curettage with high-speed burring, while five underwent en bloc resection. No local recurrence occurred in either group. Among the extended curettage group, 21 had a follow-up of more than 6 months (median follow-up: 37 months [IQR, 18-58 months]), only one complication (symptomatic hardware removal) was recorded.
Conclusions: Extended curettage with high-speed burring was associated with excellent local control and few complications, making it a desirable surgical option for CMF.
期刊介绍:
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.